Conventional Physical Therapy Treatment for Parkinson Disease
Study Summary
This trial will investigate the safety and feasibility of using a new gait rehabilitation stimulus to help patients with Parkinson's disease. The goal is to see if it can improve mobility, function, and quality of life.
- Parkinson Disease
- Gait Disorder, Sensorimotor
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 5 Secondary · Reporting Duration: It will take 10 minutes to complete this test. The speed metrics will be recorded while the primary 6MWT data is being captured.
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Conventional Physical Therapy (CPT) Group
1 of 2
Conventional Physical Therapy (CPT) Group with G-EO Training (CPT-GEO)
1 of 2
30 Total Participants · 2 Treatment Groups
Primary Treatment: Conventional Physical Therapy Treatment · No Placebo Group · Phase 1 & 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.